THE EFFECT OF A 5HT 2 RECEPTOR ANTAGONIST SARPOGRELATE (MCI-9042) TREATMENT ON PLATELET FUNCTION IN BUERGER'S DISEASE

By Rydzewski A.   Urano T.   Hachiya T.   Kaneko H.   Baba S.   Takada Y.   Takada A.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 445-452

Elsevier

Access to resources Recommend Favorite

Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589

By Johnson Fred L.   Boyer José L.   Leese Philip T.   Crean Christopher   Krishnamoorthy Ramesh   Durham Todd   Fox Anthony W.   Kellerman Donald J.  

Platelets, Vol. 18, Iss. 5, 2007-08 ,pp. : 346-356

Informa Healthcare

Access to resources Recommend Favorite

Effect of Sarpogrelate, a 5-HT_2A Antagonist, on Platelet Aggregation in Patients with Ischemic Stroke: Clinical-Pharmacological Dose-Response Study

By  

Cerebrovascular Diseases, Vol. 24, Iss. 2-3, 2007-07 ,pp. : 264-270

Karger

Access to resources Recommend Favorite

5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors.

By Karlsson C   Bodelsson G   Bodelsson M   Stjernquist M  

Human Reproduction, Vol. 12, Iss. 2, 1997-02 ,pp. : 361-367

Oxford University Press

Access to resources Recommend Favorite

A Potent 5-Hydroxytryptamine Receptor (5-HT2A) Antagonist, DV-7028, Delays Arterial Thrombosis Development in Rats - Inhibition of the serotonergic component by ketanserin

By Pawlak D.   Pawlak K.   Chabielska E.   Malyszko J.   Takada A.   Mysliwiec M.x.   Buczko W.x.  

Thrombosis Research, Vol. 90, Iss. 6, 1998-06 ,pp. : 259-270

Elsevier

Access to resources Recommend Favorite